Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/27/26 16:47 | 10/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Schachle Joseph K | NC | O | COO | 1 | S | -17 | 3.56 | 0 | -5 | 287 | D | |||||||||||||||
10/27/26 16:41 | 10/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Yerxa Benjamin R | NC | DO | P | 1 | S | -117 | 3.54 | 0 | -33 | 671 | D | |||||||||||||||
10/27/26 16:29 | 10/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | NC | O | CFO | 2 | S | -177 | 4.21 | 0 | -42 | 556 | D | |||||||||||||||
10/27/26 16:20 | 10/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Magrath George | NC | DO | CEO | 1 | S | -34 | 3.59 | 0 | -10 | 0 | 2,039 | D | ||||||||||||||
10/2/26 19:47 | 9/30/26 | IRD | Health | Drug | Pharmaceutical Preparations | Foundation Fighting Blindness Retinal Degeneration Fund | NC | DH | See Rema | 1 | S | -2,756 | 4.96 | 0 | -556 | 3,236 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |